Open AccessFrom generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
Author(s) -
Amir Hashemi-Meshkini,
Mehdi Varmaghani,
Mehdi Yousefi,
Saeed Yaghoubifard,
Hedieh-Sadat Zekri,
Shekoufeh Nikfar,
Abbas Kebriaeezadeh
Publication year - 2014
Publication title -
journal of research in pharmacy practice
Language(s) - English
Resource type - Journals
eISSN - 2319-9644
pISSN - 2279-042X
DOI - 10.4103/2279-042x.141101
Subject(s) - wilcoxon signed rank test , competition (biology) , data envelopment analysis , sign (mathematics) , scheme (mathematics) , efficiency , rank (graph theory) , business , sign test , industrial organization , competition policy , marketing , international trade , mathematics , statistics , european union , ecology , mathematical analysis , combinatorics , estimator , biology , mann–whitney u test
Brand-generic scheme was implemented in Iran to improve the competition in the pharmaceutical market. In this study, we aim to assess if this policy had any positive effect on efficiency of Iranian pharmaceutical companies.